Loading organizations...
§ Private Profile · Branford, CT, USA
Diagnostic test developer creating a non-invasive test for endometriosis using novel biomarkers and machine learning for women's healthcare.
Based in San Francisco, California, DotLab is a medical technology company that develops a non-invasive diagnostic test utilizing saliva samples and machine learning algorithms to detect endometriosis. The company's proprietary biomarker technology aims to replace invasive laparoscopic surgeries and significantly reduce diagnosis delays for a chronic condition that affects approximately 10% of women globally. Operating within the women's healthcare sector, DotLab maintains a specialized team of approximately 10 employees and has clinically validated its diagnostic approach in studies involving thousands of patients, including extensive research led by Yale University. To support ongoing clinical validation, team expansion, and commercial prescription market access, the organization secured a $10 million Series A funding round in 2019, drawing institutional investment from CooperSurgical, Tiger Global Management, and Luxor Capital. DotLab was founded in 2016 by Heather Bowerman and Dr. Hugh Taylor.
DotLab has raised $10.0M across 1 funding round.
DotLab has raised $10.0M in total across 1 funding round.
DotLab has raised $10.0M across 1 funding round. Most recently, it raised $10.0M Series A in July 2019.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jul 1, 2019 | $10M Series A | — | Luxor Capital, Tiger Global, Wilson Sonsini Goodrich & Rosati | Announced |
DotLab has raised $10.0M in total across 1 funding round.
DotLab's investors include Luxor Capital, Tiger Global, Wilson Sonsini Goodrich & Rosati.